Trial Profile
Randomized phase II study of cisplatin + gemcitabine administered either as short infusion [30 minute infusion] or at a fixed dose rate [10mg/m(2)/minute] in non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2007
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Oct 2007 Final results have been published (1088389)
- 31 Oct 2005 New trial record.